insights_auto
Why is 207940 up ၉.၉၄%?
Dive Deeperchevron_right
207940:KRX
Samsung Biologics Co Ltd
၁,၄၂၇,၀၀၀.၀၀ ₩
arrow_upward
+၉.၉၄%(+၁၂၉,၀၀၀.၀၀) 1D
အောက် ၁၉, GMT+၉ ၁၅:၃၂:၃၀ · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
၁,၂၉၀,၀၀၀ ₩
High
၁,၄၃၂,၀၀၀ ₩
Low
၁,၂၆၉,၀၀၀ ₩
Mkt. cap
ဋေ ၆.၉၃ သန်း
Avg. vol.
၄.၉၇ သောင်း
Volume
၁.၃၃ သိန်း
P/E ratio
၃၁.၀၉
52-wk high
၁,၉၇၃,၆၀၀ ₩
52-wk low
၁,၁၁၀,၄၆၀ ₩
EPS
၄၅,၈၉၇ ₩
Shares outstanding
၄.၆၃ ကုဋေ
No. of employees
၅ ထောင်
Open
၁,၂၉၀,၀၀၀ ₩
High
၁,၄၃၂,၀၀၀ ₩
Low
၁,၂၆၉,၀၀၀ ₩
Mkt. cap
ဋေ ၆.၉၃ သန်း
Avg. vol.
၄.၉၇ သောင်း
Volume
၁.၃၃ သိန်း
P/E ratio
၃၁.၀၉
52-wk high
၁,၉၇၃,၆၀၀ ₩
52-wk low
၁,၁၁၀,၄၆၀ ₩
EPS
၄၅,၈၉၇ ₩
Shares outstanding
၄.၆၃ ကုဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
파이낸셜뉴스
·
ပြီးခဲ့သည့် ၉ နာရီ
Samsung Biologics rises for third straight session amid market slump, rebounds 11% [Stock NOW]
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd